Back

Innovating antibody design driven by artificial intelligence

(Download Image)

Dr. Dante Ricci, a scientist in the Synthetic Biology group at Lawrence Livermore National Laboratory (LLNL), is at the forefront of revolutionizing medical countermeasure development through artificial intelligence (AI).

April 2, 2025

Featured Articles

CERN teams, including LLNL researchers, win 2025 Breakthrough Prize in Fundamental Physics

Simulating hot-spot formation in insensitive high explosives

LLNL and Sandia host hydrogen partner event at Livermore Open Campus

Lawrence Livermore National Laboratory

| 7000 East Avenue • Livermore, CA 94550 | LLNL-WEB-735747

Operated by the Lawrence Livermore National Security, LLC for the Department of Energy's National Nuclear Security Administration Learn about the Department of Energy's Vulnerability Disclosure Program

Innovating antibody design driven by artificial intelligence

Tags

Featured Articles